ArticleClinical and translational science2025
CYP3A Genotype Is Associated With Variability in the Exposure and Clearance of the Novel Oncogenic Transcription Inhibitor Lurbinectedin.
Rubin Lubomirov et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.